Accretive Health
AH
AH was delisted on the 14th of March, 2014.
6 hedge funds and large institutions have $17.7M invested in Accretive Health in 2015 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 0 closing their positions.
100% more funds holding
Funds holding: 3 → 6 (+3)
6% more capital invested
Capital invested by funds: $16.7M → $17.7M (+$1.01M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCMI
Paradigm Capital Management Inc
Albany,
New York
|
+$3.17M |
| 2 |
PCM
Princeton Capital Management
Red Bank,
New Jersey
|
+$238K |
| 3 |
Neuberger Berman Group
New York
|
+$112K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$111K |
| 5 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$4K |
Top Sellers
AH Hedge Fund Activity: Q1 2015 in Review
6 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in Accretive Health (AH) for Q1 2015, worth a combined $17.7M — up 6.1% from $16.7M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new AH positions and 0 closed out — a net gain of 3 holders — while 2 added to existing stakes and 0 trimmed.
The largest buyer was Paradigm Capital Management Inc, adding an estimated $3.17M.
- 6 institutional investors held Accretive Health (AH) as of Q1 2015, up from 3 in Q4 2014.
- Funds reported $17.7M of Accretive Health stock for Q1 2015, up 6.1% quarter-over-quarter.
- 3 funds opened new Accretive Health positions in Q1 2015 and 0 closed out, a net change of +3 holders.
- The largest Accretive Health buyer in Q1 2015 was Paradigm Capital Management Inc, an estimated $3.17M added.
Based on aggregated 13F filings for Q1 2015.